We are a highly experienced modern pharmaceutical consultancy that can add value, develop, and deliver impactful commercial solutions across many portfolio types.  We have specialist expertise in both the secondary care market and the primary care market in the UK and EU and have a vast array of experience across the full spectrum of the pharmaceutical industry and the NHS. The team spent most of 2020 working with first of all, NHS England and Improvement and then exclusively for the Department of Health and Social Care on COVID-19 preparedness by helping to negotiate, tender, award and secure a stockpile of critical medicines.

An area of real expertise is in product launches where we have significant experience across many portfolio types including medical devices, generic drugs, branded product launches including biosimilars